THE TEACHING CONNECTION
Th17 signaling and persistent inflammation
Th17 signaling and persistent inflammation
IL17A encodes interleukin-17A, a cytokine involved in defense at tissue barriers and inflammatory signaling. It belongs to the Th17 pathway, which is supported by signals including IL-23.
How Dr. Purser connects the pieces
Dr. Purser discusses this pathway in chronic inflammatory settings, including his sickle-cell teaching. IL17A, IL23A and IL23R represent different parts of the same network: a downstream signal, an upstream cytokine component and a receptor. Their variants do not diagnose an inflammatory disease or select an immune-targeting drug.
Where the VARS Triad and MTHFR Daily fit
In Dr. Purser’s treatment framework, the VARS Triad—VARS Glutathione, VARS SOD and VARS Catalase—together with MTHFR Daily is a central consideration when homocysteine or cytokine issues are involved. He emphasizes VARS Glutathione as a foundational functional-support component across his genetic SNP teaching. The individual gene lesson explains how its pathway connects to that broader approach.
This describes the Purser treatment model, not proof that a product corrects a variant or treats every associated condition. Product choice, formulation, sequence and amount depend on the individual assessment, existing medicines, current findings and tolerance.
A question to bring to your visit
What diagnosed condition or clinical finding makes the IL-23/Th17 pathway relevant here?
Variant lookup
These teaching identifiers include regional research markers. Match them to your original laboratory report; listing alone does not establish clinical significance or a treatment need.
Names you may see
IL-17A · Interleukin 17A




